Journals / Mersin Üniversitesi Sağlık Bilimleri Dergisi / 2024 / Cilt: 17 Sayı: 3

Investigation of leuko-glycemic index and systemic inflammatory data in patients with adenomyosis

Adenomyozis hastalarında löko-glisemik indeks ve sistemik inflamatuvar verilerin araştırılması

Cem Yalaza(Toros Üniversitesi)0000-0002-9073-5611
Ş. Efsun Antmen(MERSİN ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ)0000-0003-1270-2408
Hakan Aytan(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-2553-7715
Necmiye Canacankatan(MERSİN ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ)0000-0003-3863-962X
Ali Yıldızbakan(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-2343-2645
Hamza Yıldız(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0009-0004-6478-813X
Pages
489–495
Publication Date
2024-12-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: According to the results of the analyses of systemic inflammatory data, no statistically significant difference was found between the adenomyosis patients and the control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to investigate the leuko-glycemic index and systemic inflammatory data in adenomyosis patients to determine their role and potential effects in the pathogenesis of adenomyosis.
📊
Key Findings & Data:Method: The study groups consisted of 166 patients diagnosed with adenomyosis by histopathological examinations and 55 control subjects without adenomyosis.
💡
Conclusion & Impact:Results: According to the results of the analyses of systemic inflammatory data, no statistically significant difference was found between the adenomyosis patients and the control group.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Löko-glisemik indeks · sistemik inflamasyon · adenomyozis

Abstract

Aim: The aim of this study was to investigate the leuko-glycemic index and systemic inflammatory data in adenomyosis patients to determine their role and potential effects in the pathogenesis of adenomyosis. Method: The study groups consisted of 166 patients diagnosed with adenomyosis by histopathological examinations and 55 control subjects without adenomyosis. Leuko-glycemic index, systemic inflammatory parameters and demographic data of the study group were retrospectively analysed and recorded. The data obtained were statistically analysed to determine the differences between adenomyosis and control group. Results: According to the results of the analyses of systemic inflammatory data, no statistically significant difference was found between the adenomyosis patients and the control group. Statistical analyses of demographic data also showed no significant difference between the groups. Conclusion: The leuko-glycemic index and systemic inflammatory markers were not significantly different in adenomyosis patients compared with the control group. This result reflects the uncertainty in the literature about the role of inflammation in the pathogenesis of adenomyosis. Further prospective studies with larger sample groups will provide a better understanding of the relationship between adenomyosis and inflammation.

Özet

Amaç: Bu çalışma, adenomyozis hastalarında löko-glisemik indeks ve sistemik inflamatuvar verilerin araştırılarak adenomyozis patogenezindeki yerini ve potansiyel etkilerini belirlemeyi amaçlamaktadır. Yöntem: Çalışma grupları histopatolojik incelemelerle adenomyozis tanısı konulmuş 166 hasta ile adenomyozisi olmayan 55 kontrol grubu bireylerinden oluşturulmuştur. Löko-glisemik indeks ve sistemik inflamatuvar parametreleri ile çalışma grubunu oluşturan bireylerin demografik verileri retrospektif olarak incelenmiş ve kaydedilmiştir. Elde edilen veriler adenomyozis ve kontrol grubu arasındaki farkların belirlenebilmesi adına istatistiksel olarak analiz edilmiştir. Bulgular: Çalışmada incelenen sistemik inflamatuvar verilerin analiz sonuçlarına göre, adenomyozis hastaları ile kontrol grubu arasında istatistiksel açıdan anlamlı bir farklılık tespit edilmemiştir. Demografik veriler açısından yapılan istatistiksel analizlerde de gruplar arasında anlamlı bir fark bulunamamıştır. Sonuç: Adenomyozis hastalarında löko-glisemik indeks ve sistemik inflamatuvar belirteçler, kontrol grubuyla karşılaştırıldığında anlamlı bir farklılık göstermemektedir. Bu sonuç, adenomyozis patogenezinde inflamasyonun rolü hakkında literatürdeki belirsizliği yansıtmaktadır. Daha geniş örneklem grupları ve prospektif olarak yapılacak araştırmalar, adenomyozis ve inflamasyon arasındaki ilişkinin daha iyi anlaşılmasını sağlayacaktır.

🔖

Cite This Article

Yalaza, C., Antmen, Ş. E., Aytan, H., Canacankatan, N., Yıldızbakan, A., Yıldız, H. (2024). Investigation of leuko-glycemic index and systemic inflammatory data in patients with adenomyosis. Mersin Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 17 Sayı: 3, 489–495. https://ajindex.com/articles/1109046

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Kishi Y, Shimada K, Fujii T, et al. Phenotypic characterization of adenomyosis occurring at the inner and outer myometrium. PLoS ONE. 2017;12(12): e0189522.
  2. Levgur M, Abadi MA, Tucker A. Adenomyosis: Symptoms, histology,and pergnancy termination. Obstet. Gynecology. 2000;95:688-91.
  3. Antero MF, Ayhan A, Segars J, Shih IM. Pathology and Pathogenesis of Adenomyosis. Semin Reprod Med. 2020;38(2-03):108-118.
  4. Orazov MR, Radzinsky VE, Nosenko EN, Khamoshina MB, Dukhin AO, Lebedeva MG. Immune-inflammatory predictors of the pelvic pain syndrome associated with adenomyosis. Gynecol Endocrinol. 2017;33(sup1):44-46.
  5. Suszczyk D, Skiba W, Jakubowicz-Gil J, Kotarski J, Wertel I. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art. Cells. 2021;10(3):677.
  6. Donnez J, Cacciottola L. Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options. Int J Mol Sci. 2022;23(3):1518.
  7. Kapoor R, Stratopoulou CA, Dolmans MM. Pathogenesis of Endometriosis: New Insights into Prospective Therapies. Int J Mol Sci. 2021;22:11700.
  8. Peker T, Özbek M, Boyraz B, Aslan Sf, Demir M, Aslan B. Prognostic value of the leuko-glycemic index in coronary chronic total occlusion patients. Eur Res J. 2023;9(5):1099-1104.
  9. Qi LY, Liu HX, Cheng LC, et al. Prognostic Value of the Leuko-Glycemic Index in Acute Myocardial Infarction Patients with or without Diabetes. Diabetes Metab Syndr Obes. 2022;15:1725-1736.
  10. Haybar H, Pezeshki SMS, Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?. Exp Mol Pathol. 2019;110:104267.
  11. Tudurachi BS, Anghel L, Tudurachi A, Sascău RA, Stătescu C. Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients. International Journal of Molecular Sciences. 2023; 24(18):14378.
  12. Bourdon M, Santulli P, Jeljeli M, et al. Immunological changes associated with adenomyosis: a systematic review. Hum Reprod Update. 2021;27(1):108-129.
  13. Li Q, Shi J, Yi D, et al. The pathogenesis of endometriosis and adenomyosis: insights from single-cell RNA sequencing†. Biol Reprod. 2024;110(5):854-865.
  14. Peng L, Luo X, Cao B, Wang X. Exploring the link: Systemic immune-inflammation index as a marker in endometriosis-Insights from the NHANES 2001-2006 cross-sectional study. PLoS One. 2024;19(6):e0304591.
  15. Symons LK, Miller JE, Kay VR, et al. The Immunopathophysiology of Endometriosis. Trends Mol Med. 2018;24(9):748-762.
  16. Sadeghi R, Haji Aghajani M, Parandin R, Taherpour N, Ahmadzadeh K, Sarveazad A. Leuko-Glycemic Index in the Prognosis of Acute Myocardial Infarction; a Cohort Study on Coronary Angiography and Angioplasty Registry. Arch Acad Emerg Med. 2023;11(1):e63
  17. Levgur M, Abadi MA, Tucker A. Adenomyosis: Symptoms, histology,and pergnancy termination. Obstet. Gynecology. 2000;95:688-91.